Product
Pneumococcal 13-valent conjugate vaccine
Aliases
Prevenar 13, Prevnar 13®
3 clinical trials
2 indications
Indication
Volunteers (Meningococcal Infection)Indication
DiphtheriaClinical trial
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South AfricaStatus: Completed, Estimated PCD: 2023-01-28
Clinical trial
A Phase IV, Single-blind, Randomised, Controlled, Multi-country Study to Evaluate the Immunogenicity and Safety of GSK's Infanrix Hexa (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis (DTaP5-HBV-IPV Hib), When Administered Intramuscularly According to a 2-, 4- and 12-month Schedule in Healthy Infants and ToddlersStatus: Completed, Estimated PCD: 2022-07-25
Clinical trial
A Phase III, Partially Modified Double-blind, Randomized, Parallel-group, Active-controlled, Multi-center Study to Compare the Immunogenicity and Describe the Safety of MenACYW Conjugate Vaccine and MENVEO® When Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in the United StatesStatus: Completed, Estimated PCD: 2023-09-22